Timor Baasov
Technion Israel Institute Of Technology Haifa 3200003 Israel
Haifa, HA 32000, Israel
Haifa, HA 32000, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Towards catalytic fluoroquinolones: from metal-catalyzed to metal-free DNA cleavage.
Journal: RSC medicinal chemistry
Published: December 12, 2024
Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases.
Journal: ACS medicinal chemistry letters
Published: March 09, 2023
Dynamic Intramolecular Cap for Preserving Metallodrug Integrity─A Case of Catalytic Fluoroquinolones.
Journal: Journal of medicinal chemistry
Published: October 11, 2022
Toward Catalytic Antibiotics: Redesign of Fluoroquinolones to Catalytically Fragment Chromosomal DNA.
Journal: ACS infectious diseases
Published: January 15, 2021
Cross-utilization of β-galactosides and cellobiose in Geobacillus stearothermophilus.
Journal: The Journal of biological chemistry
Published: April 28, 2020
Towards Catalytic Antibiotics: Redesign of Aminoglycosides To Catalytically Disable Bacterial Ribosomes.
Journal: Chembiochem : a European journal of chemical biology
Published: September 13, 2018
Exploring eukaryotic versus prokaryotic ribosomal RNA recognition with aminoglycoside derivatives.
Journal: MedChemComm
Published: January 01, 2018
Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
Journal: Bioorganic & medicinal chemistry
Published: January 15, 2017
New inducible genetic method reveals critical roles of GABA in the control of feeding and metabolism.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 16, 2016
Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs).
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: February 18, 2016
Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations.
Journal: ACS medicinal chemistry letters
Published: January 07, 2016
Last Updated: 09/26/2026